The USAID - US Agency for International Development, has pledged $2.3 million to procure 4.8 million malaria prevention tablets from Nigerian pharmaceutical company.
A statement by the US consulate in Lagos indicates that the procurement is part of the U.S. President’s Malaria Initiative, highlighting America’s ongoing support for Nigeria’s healthcare system, especially in providing life-saving treatments to vulnerable communities.
It explains that the USAID’s commitment is set to strengthen access to affordable, high-quality malaria medication across Nigeria and West Africa.
The statement says in a milestone development, Nigerian Phamaceutical company (Swipha) recently earned WHO prequalification for its sulfadoxine/pyrimethamine tablets, becoming the first pharmaceutical company in West Africa to do so.
Comments
Post a Comment